Ozempic and Wegovy surge to national approval with most U.S. adults considering it ‘a good thing’ to treat obesity
A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...
A new definition of obesity goes beyond BMI. What this could mean for you
A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
BMI is wrong way to measure obesity, researchers say — here’s what they recommend instead
A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.
health.wusf.usf.edu1d
The obesity rate in America keeps on growing and is expected to get even bigger
A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.
Healio9h
Most adults with overweight or obesity discontinue GLP-1 therapy within 2 years
More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...
This disease kills more people than all cancers and accidents combined
Heart disease remains the top killer of Americans as risk factors continue to grow. Get the latest statistics from the ...
Healio7d
Novel obesity drug induces up to 22% weight loss with no safety concerns
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...
BioSpace4d
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy—Is It Enough?
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...